| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
215,848 | 208,200 | 203,825 | 219,786 | 271,518 |
| Cost of Revenue
|
-120,672 | -115,934 | -112,063 | -152,829 | -175,018 |
|
Gross Profit
|
95,176 | 92,266 | 91,762 | 66,957 | 96,500 |
| Selling, General and Administrative Expenses
|
-97,100 | -89,107 | -87,499 | -104,428 | -110,356 |
|
Research and Development Expenses
|
-38,095 | -37,731 | -41,578 | -50,060 | -56,026 |
|
Operating Income/Expenses
|
-135,195 | -126,838 | -129,077 | -154,488 | -166,382 |
|
Total Operating Profit/Loss
|
-40,019 | -34,572 | -37,315 | -87,531 | -69,882 |
| Total Net Finance Income/Expense
|
19,747 | 21,119 | 23,214 | 27,353 | 12,786 |
|
Amortization and Accretion of Securities
|
953 | 953 | 389 | -754 | -1,820 |
| Net Investment Income
|
-153 | -153 | -1,253 | -2,449 | 2,416 |
|
Non-Operating Income/Expenses, Total
|
20,547 | 21,919 | 22,350 | 24,150 | 13,382 |
|
Pretax Income
|
-19,472 | -12,653 | -14,965 | -63,381 | -56,500 |
|
Provision for Income Tax
|
-852 | -865 | -1,835 | -970 | -22,565 |
|
Net Income from Continuing Operations
|
-20,324 | -13,518 | -16,800 | -64,351 | -79,065 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-20,324 | -13,518 | -16,800 | -64,351 | -79,065 |
|
Net Income after Non-Controlling/Minority Interests
|
-20,324 | -13,518 | -16,800 | -64,351 | -79,065 |
|
Net Income Available to Common Stockholders
|
-20,324 | -13,518 | -16,800 | -64,351 | -79,065 |
|
Diluted Net Income Available to Common Stockholders
|
-20,324 | -13,518 | -16,800 | -64,351 | -79,065 |
| Basic EPS
|
-0.47 | -0.30 | -0.35 | -1.31 | -1.59 |
| Diluted EPS
|
-0.48 | -0.30 | -0.35 | -1.31 | -1.59 |
|
Basic Weighted Average Shares Outstanding
|
44,279.53 | 45,244.52 | 47,482.82 | 49,160.27 | 49,791.66 |
|
Diluted Weighted Average Shares Outstanding
|
44,279.53 | 45,244.52 | 47,482.82 | 49,160.27 | 49,791.66 |
|
Reported Normalized Diluted EPS
|
0.31 | 0.31 | 0.20 | -0.42 | -0.65 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-40,083 | -34,636 | -38,426 | -90,970 | -69,551 |
|
EBITDA
|
-27,472 | -22,739 | -25,379 | -76,270 | -55,986 |
|
Normalized EBITDA
|
4,079 | 1,503 | 331 | -30,867 | -8,300 |
|
Normalized Income
|
-4,224.07 | 14,353 | 10,113 | -20,432 | -32,629 |
|
Total Unusual Items
|
20,909 | 22,338 | 24,865 | 36,565 | 45,584 |
|
Total Unusual Items Excluding Goodwill
|
20,909 | 22,338 | 24,865 | 36,565 | 45,584 |
12/31/2022 - 4/2/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade